...
首页> 外文期刊>New Journal of Chemistry >Improved targeting for photodynamic therapy via a biotin-phthalocyanine conjugate: synthesis, photophysical and photochemical measurements, and in vitro cytotoxicity assay
【24h】

Improved targeting for photodynamic therapy via a biotin-phthalocyanine conjugate: synthesis, photophysical and photochemical measurements, and in vitro cytotoxicity assay

机译:通过生物素 - 酞菁缀合物进行光动力治疗的改进:合成,光学和光化学测量,体外细胞毒性测定

获取原文
获取原文并翻译 | 示例

摘要

In this study, the peripherally biotin-substituted zinc(ii) phthalocyanine (Pc2) was synthesized as a photosensitizer for the treatment of cancer by photodynamic therapy. The photophysico-chemical properties of the zinc(ii) phthalocyanine-bearing mono-biotin and three branched polyoxyethylene groups were studied in DMSO. The photodynamic activities of this compound were tested on HeLa cervical carcinoma cells and HuH-7 human liver carcinoma cells. The dark toxicity and photosensitizing effect of the conjugate were compared to those of amino-functionalized zinc(ii) phthalocyanine (Pc1) to determine the effect of the biotin group on the photodynamic activity. According to the results, Pc1 showed good photodynamic activity reaction against HeLa and HuH-7 cancer cells. Although the results of the photochemical and photophysical data of Pc1 and Pc2 were close, the in vitro studies of these compounds (1 and 2) have shown that the biotin-substituted conjugate (Pc2) more effectively decreased cell survival than the non-biotin-bearing derivative (Pc1) due to the targeting effect of the biotin. Furthermore, the apoptosis ratio of 2 by the HeLa and HuH-7 cells was detected by flow cytometry via Annexin V/PI double-staining assay. The percentages of the late apoptotic cells were 3.5% and 0.4% in the control groups of HuH-7 and HeLa cells, respectively. The late apoptotic cells increased under light conditions in both HeLa (63.9%) and HuH-7 (83.6%) cells compared to dark conditions (HuH-7, 1% and HeLa, 0.4%). The cellular uptake of Pc2 was relatively high (34.5-fold in HuH-7 and 459 fold in HeLa cells) and localized in the cytoplasm in different cancer model cells. Moreover, the Pc2 treatment and illumination strictly reduced the cell colony forming capacity. The photodynamic activity of the biotin conjugate can be related to the high cellular uptake and/or singlet oxygen generation yield of this photosensitizer.
机译:在该研究中,将外周生物素取代的锌(II)酞菁(PC2)作为光敏剂合成,用于通过光动力疗法治疗癌症。在DMSO中研究了锌(II)锌(II)磷酸含量的单氰基 - 生物素和三种支化聚氧乙烯的光学化学性质。在HeLa宫颈癌细胞和Huh-7人肝癌细胞上测试该化合物的光动力活性。将缀合物的暗毒性和光敏效应与氨基官能化锌(II)酞菁(PC1)进行比较,以确定生物素基团对光动力活性的影响。根据结果​​,PC1显示出对Hela和Huh-7癌细胞的良好的光动力活性反应。虽然PC1和PC2的光化学和光物理数据的结果是接近的,但这些化合物(1和2)的体外研究表明,生物素取代的缀合物(PC2)比非生物素更有效地降低了细胞存活率 - 由于生物素的靶向效果,轴承衍生物(PC1)。此外,通过膜蛋白V / PI双染料测定法通过流式细胞术检测Hela和Huh-7细胞的凋亡比。凋亡细胞的百分比分别分别在Huh-7和HeLa细胞的对照组中为3.5%和0.4%。与暗条件(Huh-7,1%和Hela,0.4%)相比,在HeLa(63.9%)和Huh-7(83.6%)细胞中,晚期凋亡细胞在光照条件下增加。 PC2的细胞摄取相对较高(在HUH-7和459倍的HUH-7和459折叠中折叠的34.5倍),并在不同癌症模型细胞中的细胞质中局部。此外,PC2处理和照明严格降低了细胞落体形成能力。生物素缀合物的光动力活性可以与该光敏剂的高细胞摄取和/或单次磷产生产率有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号